News

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to a new gene therapy for Amyotrophic Lateral ...
KLTO‑202 is an experimental gene therapy that would deliver the instructions for a protein that may reduce inflammation and oxidative stress.
A noninvasive therapy delivering gentle spinal stimulation was shown to slow disease progression and extend survival in an ...
The ALS market is witnessing robust growth driven by increased disease awareness, advancements in genetic research, and an expanding pipeline of ther ...
Blood tests could pave the way for distinguishing between Alzheimer’s, Parkinson’s and some dementias, aiding early treatment for brain diseases.
Every year, roughly 5,000 people are diagnosed with Amyotrophic Lateral Sclerosis, which is why ALS in the Heartland choosing to raise awareness of the disease in Nebraska. ALS in the Heartland, ...
Matt Keil, who was the bassist of Canadian band Comeback Kid before becoming a realtor in the Twin Cities, has died following ...
The Model City hosted a large cornhole tournament on Sunday for a worthy cause. The first Paul Codispoti Memorial Cornhole ...
The ALS Market report offers 10 years of Market forecast based on the epidemiological model of amyotrophic lateral sclerosis in 7MM. LAS VEGAS, Jan. 18, 2021 /PRNewswire/ -- The surge in the ...